Increased turnover of foxp3high regulatory T cells is associated with hyperactivation and disease progression of chronic HIV-1 infection

Journal of Acquired Immune Deficiency Syndromes

Volumn 54, Issue 5, 2010, Pages 455-462

  Xing, Shaojun ^a,b   Fu, Junliang ^b   Zhang, Zheng ^b   Gao, Yingying ^b   Jiao, Yanmei ^c   Kang, Fubiao ^b   Zhang, Jiyuan ^b   Zhou, Chunbao ^b   Wu, Hao ^c   Wang, Fu Sheng ^a,b  

^a INSTITUTE OF BIOPHYSICS   (China)

^b BEIJING 302 HOSPITAL   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

FoxP3; HIV 1; homeostasis; pathogenesis; regulatory T cells

Indexed keywords

CASPASE 3; CD38 ANTIGEN; HLA DR ANTIGEN; KI 67 ANTIGEN; LIPOCORTIN 5; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ADULT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADULT; ANNEXIN A5; ANTIGENS, CD38; APOPTOSIS; CASPASE 3; DISEASE PROGRESSION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HIV INFECTIONS; HIV-1; HLA-DR ANTIGENS; HUMANS; KI-67 ANTIGEN; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY;

EID: 77955013981     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181e453b9     Document Type: Article

References (45)

1. Douek DC, Picker LJ, Koup RA. T cell dynamics in HIV-1 infection. Annu Rev Immunol. 2003;21:265-304.
2. Hellerstein M, Hanley MB, Cesar D, et al. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat Med. 1999;5:83-89.
3. Giorgi JV, Hultin LE, McKeating JA, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis. 1999;179:859-870.
4. Hazenberg MD, Otto SA, van Benthem BH, et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS. 2003;17:1881-1888.
5. + T cells under successful highly active antiretroviral therapy, J Acquir Immune Defic Syndr, 2005, 38, 373-381.
6. Douek DC, Betts MR, Hill BJ, et al. Evidence for increased T cell turnover and decreased thymic output in HIV infection. J Immunol. 2001;167: 6663-6668.
7. Mohri H, Perelson AS, Tung K, et al. Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. J Exp Med. 2001;194:1277-1287.
8. Sieg SF, Bazdar DA, Lederman MM. S-phase entry leads to cell death in circulating T cells from HIV-infected persons. J Leukoc Biol. 2008;83: 1382-1387.
9. + T-cell depletion in HIV infection: are we closer to understanding the cause? Nat Med. 2002;8:319-323.
10. + regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol. 2004;22:531-562.
11. De St Groth BF, Landay AL. Regulatory T cells in HIV infection: pathogenic or protective participants in the immune response? AIDS. 2008;22:671-683.
12. + regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood. 2004;104:3249-3256.
13. + regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol. 2004;78:2454-2459.
14. Kinter AL, Hennessey M, Bell A, et al. CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J Exp Med. 2004;200:331-343.
15. + regulatory T cells in antiretroviral-naive HIV patients. AIDS. 2006;20:1669-1671.
16. + regulatory T cells to immune status in HIV-infected patients. AIDS. 2005; 19:879-886.
17. Eggena MP, Barugahare B, Jones N, et al. Depletion of regulatory T cells in HIV infection is associated with immune activation. J Immunol. 2005; 174:4407-4414.
18. Card CM, McLaren PJ, Wachihi C, et al. Decreased immune activation in resistance to HIV-1 infection is associated with an elevated frequency of CD4(+)CD25(+)FOXP3(+) regulatory T cells. J Infect Dis. 2009;199: 1318-1322.
19. + T cell activation levels in primary HIV-1 infection. J Leukoc Biol. 2008;83:254-262.
20. + regulatory T cells are derived by rapid turnover of memory populations in vivo. J Clin Invest. 2006;116:2423-2433.
21. + T cells in the periphery. Nat Rev Immunol. 2007;7:231-237.
22. Jiao Y, Fu J, Xing S, et al. The decrease of regulatory T cells correlates with excessive activation and apoptosis of CD8(+) T cells in HIV-1-infected typical progressors, but not in long-term non-progressors. Immunology. 2009;128:e366-e375.
23. + T lymphocytes in HIV-1 infection as measured by Ki-67 antigen. J Exp Med. 1998;187:1295-1303.
24. Hazenberg MD, Stuart JW, Otto SA, et al. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood. 2000;95:249-255.
25. + T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection. J Infect Dis. 1998;178:1279-1287.
26. + T cells. J Immunol. 2005;174:2196-2204.
27. + T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosis. Blood. 2005;106:3524-3531.
28. + regulatory T cells play an important role in acute HIV-1 infection in humanized Rag2-/-gammaC-/-mice in vivo. Blood. 2008;112:2858-2868.
29. + Treg in HIV-1-infected patients with low CD4 counts. Eur J Immunol. 2009;39:301-309.
30. Gaardbo JC, Nielsen SD, Vedel SJ, et al. Regulatory T cells in human immunodeficiency virus-infected patients are elevated and independent of immunological and virological status, as well as initiation of highly active anti-retroviral therapy. Clin Exp Immunol. 2008;154:80-86.
31. + regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. Blood. 2006;108: 3072-3078.
32. + regulatory T cells at the single-cell level. Eur J Immunol. 2005;35:1681-1691.
33. + T cells. Eur J Immunol. 2007;37:129-138.
34. + regulatory T cells in patients chronically infected with human immunodeficiency virus and/or hepatitis C virus. Clin Exp Immunol. 2009;155:35-43.
35. + cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;16:83-92.
36. Deeks SG, Walker BD. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity. 2007;27:406-416.
37. Lim A, Tan D, Price P, et al. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy. AIDS. 2007;21: 1525-1534.
38. Kolte L, Gaardbo JC, Skogstrand K, et al. Increased levels of regulatory T cells (Tregs) in human immunodeficiency virus-infected patients after 5 years of highly active anti-retroviral therapy may be due to increased thymic production of naive Tregs. Clin Exp Immunol. 2009; 155:44-52.
39. Andersson J, Boasso A, Nilsson J, et al. The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J Immunol. 2005;174:3143-3147.
40. + cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection. J Virol. 2006;80:10162-10172.
41. + regulatory T cells. Nat Med. 2005;11:1238-1243.
42. + T-cells and is expressed by diabetes-suppressive dendritic cells. Diabetes. 2006;55:158-170.
43. + regulatory T cell development. J Immunol. 2008;181:3285-3290.
44. Pereira LE, Villinger F, Onlamoon N, et al. Simian immunodeficiency virus (SIV) infection influences the level and function of regulatory T cells in SIV-infected rhesus macaques but not SIV-infected sooty mangabeys. J Virol. 2007;81:4445-4456.
45. Kinter AL, Horak R, Sion M, et al. CD25(+) Regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8(+) T cells in vitro. AIDS Res Hum Retroviruses. 2007;23:438-450.